Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 21,073-21,084 of 23,847

Other study type icon

CompletedNCT00001170

the Psychological Development of Children of Parents With and Without Affective Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda

Bipolarity, DepressionOther

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Drug study icon

WithdrawnNCT04592159

the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in people with PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

PTSDDrugFrom 18 Years to 70 Years

Countries
Sponsor: Jazz Pharmaceuticals
Condition: PTSD

Behavioral study icon

CompletedNCT01074294

Safety and Efficacy of OPC-34712 for ADHD

This study is completed in the United States. It is testing Safety and Efficacy of OPC-34712 for ADHD.

Multiple locations, including Little Rock

ADHDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

TerminatedNCT05322954

the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Madison

AddictionDrugFrom 25 Years to 65 Years

Countries: United States
Sponsor: University of Wisconsin, Madison
Condition: Addiction

Drug study icon

CompletedNCT01377233

Safety study of once Weekly Zicronapine in schizophrenia

This study is completed in the United States. It is testing once Weekly Zicronapine for schizophrenia.

Multiple locations, including Garden Grove

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Biological study icon

CompletedNCT01903655

Telomere-telomerase System and the Expression of Candidate Genes for depression

This study is completed in France. It is testing Telomere-telomerase System and the Expression of Candidate Genes for depression.

In Dijon

DepressionOther

Countries: France
Sponsor: Centre Hospitalier Universitaire Dijon
Condition: Depression

Behavioral study icon

CompletedNCT01642030

the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore

AddictionBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Drug study icon

CompletedNCT02795637

What the Body Does to the Drug for ADHD

This study is completed in the United States. It is testing what the Body Does to the Drug for ADHD.

Multiple locations, including Miami

ADHD, Eating disordersDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Sumitomo Pharma America, Inc.
Condition: ADHD, Eating disorders

Drug study icon

CompletedNCT00080327

Three Doses of Aripiprazole in people with Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Wallingford

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00879151

Treatment for Adolescents With Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Stanford

Eating disordersBehavioralFrom 12 Years to 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Eating disorders

Behavioral study icon

CompletedNCT02252068

Treatment for Opioid Dependence and Anxiety Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont

Anxiety, AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Anxiety, Addiction

Behavioral study icon

CompletedNCT05838625

Two Digital Therapeutics for Experiential Negative Symptoms of Schizophrenia

This study exists to see whether the medication Two can play a useful role in care. Researchers are trying to understand whether the medication Two can make support easier to access outside standard clinic visits.

Multiple locations, including Chandler

SchizophreniaBehavioralOver 18 Years

Countries: United States
Sponsor: Click Therapeutics, Inc.
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.